Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
AcelRx Pharmaceuticals, Inc (ACRX)
Pharmaceutical Preparations
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain.
1850 GATEWAY DRIVE, SUITE 175
SAN MATEO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
02/11/2011
Market Cap
14,578,978
Shares Outstanding
16,950,000
Weighted SO
16,952,269
Total Employees
N/A
Upcoming Earnings
04/04/2024
Beta
0.5170
Last Div
0.0000
Range
0.425-2.3
Chg
0.0600
Avg Vol
138824
Mkt Cap
14578978
Exch
NASDAQ
Country
US
Phone
650 216 3500
DCF Diff
0.3756
DCF
2.3657
Div Yield
0.0000
P/S
23.4389
EV Multiple
-0.0980
P/FV
0.7872
Div Yield %
0.0000
P/E
-1.8301
PEG
0.0183
Payout
-0.0028
Current Ratio
4.0353
Quick Ratio
3.7462
Cash Ratio
3.7462
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
126.4742
CCC
-126.4742
Gross Margin
-3.7604
Op Margin
-23.3569
Pretax Margin
-21.3215
Net Margin
-12.6608
Eff Tax Rate
0.3973
ROA
-0.3385
ROE
-0.4862
ROCE
-0.7379
NI/EBT
0.5938
EBT/EBIT
0.9129
EBIT/Rev
-23.3569
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
-19.0157
CF/Debt
0.0000
Equity Multi
1.2706
Rec Turnover
0.0000
Pay Turnover
2.8860
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0267
OCF/Share
-1.1312
FCF/Share
-1.1400
Cash/Share
0.7990
OCF/Sales
-30.4759
FCF/OCF
1.0078
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
-128.0811
Div&CapEx Cov
-111.5059
P/BV
0.7872
P/B
0.7872
P/S
23.4389
P/E
-1.8301
P/FCF
-0.7631
P/OCF
-0.7603
P/CF
-0.7603
PEG
0.0183
P/S
23.4389
EV Multiple
-0.0980
P/FV
0.7872
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Revenue | 740.00K | ▼ 613.00K | ▼ 475.00K | ▲ 738.00K | ▼ 2.00K | ▲ 252.00K | ▼ 117.00K |
Cost Of Revenue | 962.00K | ▲ 1.24M | ▲ 1.62M | ▼ 1.30M | ▼ 1.23M | ▼ 362.00K | ▼ 0.00 |
Gross Profit | -222.00K | ▼ -625.00K | ▼ -1.14M | ▲ -562.00K | ▼ -1.23M | ▲ -110.00K | ▲ 117.00K |
Gross Profit Ratio | -0.30 | ▼ -1.02 | ▼ -2.41 | ▲ -0.76 | ▼ -100.00 | ▲ -0.44 | ▲ 1.00 |
Research And Development Expenses | 3.68M | ▼ 2.70M | ▼ 1.06M | ▼ 836.00K | ▲ 986.00K | ▲ 1.03M | ▲ 1.18M |
General And Administrative Expenses | 3.91M | ▲ 7.65M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 3.91M | ▲ 7.65M | ▲ 12.79M | ▼ 7.85M | ▼ 5.96M | ▲ 6.25M | ▼ 2.25M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 4.95M | ▼ 0.00 |
Operating Expenses | 7.59M | ▲ 10.35M | ▲ 13.85M | ▼ 8.68M | ▼ 6.94M | ▲ 7.28M | ▼ 3.43M |
Cost And Expenses | 8.55M | ▲ 11.59M | ▲ 15.47M | ▼ 9.98M | ▼ 8.18M | ▼ 7.64M | ▼ 3.43M |
Interest Income | 8.66M | ▼ 495.00K | ▲ 1.40M | ▼ 1.08M | ▼ 725.00K | ▼ 137.00K | ▲ 1.89M |
Interest Expense | 11.44M | ▼ 2.08M | ▼ 831.00K | ▼ 754.00K | ▼ 467.00K | ▼ 189.00K | ▼ 0.00 |
Depreciation And Amortization | 356.00K | ▼ 140.00K | ▼ 46.47K | ▲ 55.13K | ▲ 71.39K | ▼ 54.88K | ▼ -39.59K |
Ebitda | 1.21M | ▼ -10.48M | ▼ -13.59M | ▲ -8.16M | ▲ -6.99M | ▼ -7.25M | ▲ -1.42M |
Ebitda Ratio | 1.63 | ▼ -17.10 | ▼ -28.61 | ▲ -11.06 | ▼ -100.00 | ▲ -28.77 | ▲ -12.10 |
Operating Income | -7.81M | ▼ -10.98M | ▼ -14.99M | ▲ -9.24M | ▲ -8.18M | ▲ -7.43M | ▲ -3.31M |
Operating Income Ratio | -10.55 | ▼ -17.91 | ▼ -31.56 | ▲ -12.53 | ▼ -1,000.00 | ▲ -29.50 | ▲ -28.28 |
Total Other Income Expenses Net | -2.78M | ▲ -1.58M | ▲ 569.00K | ▼ 326.00K | ▼ -467.00K | ▲ -52.00K | ▲ 1.89M |
Income Before Tax | -10.59M | ▼ -12.56M | ▼ -14.42M | ▲ -8.92M | ▲ -7.92M | ▲ -7.49M | ▲ -1.42M |
Income Before Tax Ratio | -14.31 | ▼ -20.49 | ▼ -30.36 | ▲ -12.08 | ▼ -100.00 | ▲ -29.70 | ▲ -12.10 |
Income Tax Expense | -703.00K | ▲ 355.00K | ▲ 885.00K | ▼ 698.00K | ▼ 467.00K | ▼ -1.00K | ▲ 2.00K |
Net Income | -9.89M | ▼ -12.56M | ▼ -14.42M | ▲ -8.92M | ▲ -7.92M | ▲ -7.48M | ▲ -1.36M |
Net Income Ratio | -13.36 | ▼ -20.49 | ▼ -30.36 | ▲ -12.08 | ▼ -100.00 | ▲ -29.70 | ▲ -11.60 |
Eps | -3.88 | ▲ -3.56 | ▼ -3.63 | ▲ -1.93 | ▲ -1.24 | ▲ -1.01 | ▲ -0.08 |
Eps Diluted | -3.88 | ▲ -3.56 | ▼ -3.63 | ▲ -1.93 | ▲ -1.24 | ▲ -1.01 | ▲ -0.08 |
Weighted Average Shs Out | 2.52M | ▲ 3.49M | ▲ 3.98M | ▲ 4.61M | ▲ 6.38M | ▲ 7.41M | ▲ 16.76M |
Weighted Average Shs Out Dil | 2.55M | ▲ 3.53M | ▲ 3.98M | ▲ 4.61M | ▲ 6.38M | ▲ 7.41M | ▲ 16.76M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 52.90M | ▲ 87.98M | ▼ 14.68M | ▲ 27.27M | ▼ 12.66M | ▲ 15.28M | ▼ 13.39M |
Short Term Investments | 7.57M | ▲ 17.74M | ▲ 51.45M | ▼ 15.61M | ▲ 38.97M | ▼ 495.00K | ▼ 0.00 |
Cash And Short Term Investments | 60.47M | ▲ 105.72M | ▼ 66.14M | ▼ 42.89M | ▲ 51.63M | ▼ 15.77M | ▼ 13.39M |
Net Receivables | 1.53M | ▼ 401.00K | ▲ 520.00K | ▲ 635.00K | ▼ 160.00K | ▲ 309.00K | ▼ 0.00 |
Inventory | 956.00K | ▼ 854.00K | ▲ 3.30M | ▼ 1.63M | ▼ 1.11M | ▲ 1.18M | ▼ 0.00 |
Other Current Assets | 455.00K | ▲ 1.02M | ▲ 1.74M | ▼ 1.68M | ▲ 2.59M | ▼ 2.31M | ▼ 1.02M |
Total Current Assets | 63.41M | ▲ 107.99M | ▼ 71.69M | ▼ 46.83M | ▲ 55.49M | ▼ 24.57M | ▼ 14.42M |
Property Plant Equipment Net | 11.05M | ▲ 11.48M | ▲ 18.48M | ▲ 18.81M | ▲ 20.23M | ▼ 13.86M | ▼ 0.00 |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 8.82M | 8.82M |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 8.82M | 8.82M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 1.09M | ▼ 1.06M | ▲ 1.19M | ▼ 656.00K | ▲ 2.17M | ▼ 246.00K | ▼ 20.00K |
Total Non Current Assets | 12.14M | ▲ 12.54M | ▲ 19.67M | ▼ 19.47M | ▲ 22.40M | ▲ 22.92M | ▼ 8.84M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 75.55M | ▲ 120.53M | ▼ 91.36M | ▼ 66.30M | ▲ 77.89M | ▼ 47.49M | ▼ 23.26M |
Account Payables | 1.42M | ▲ 2.07M | ▼ 1.72M | ▲ 2.74M | ▼ 2.12M | ▼ 2.04M | ▼ 1.03M |
Short Term Debt | 7.73M | ▲ 8.61M | ▼ 5.60M | ▲ 9.85M | ▲ 9.86M | ▼ 7.46M | ▼ 0.00 |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 362.00K | ▼ 315.00K | ▲ 411.00K | ▼ 49.00K | ▲ 86.00K | ▲ 115.00K | ▼ 0.00 |
Other Current Liabilities | 4.15M | ▲ 4.93M | ▲ 5.88M | ▼ 5.00M | ▲ 6.44M | ▼ 4.15M | ▼ 2.55M |
Total Current Liabilities | 13.66M | ▲ 15.93M | ▼ 13.61M | ▲ 17.64M | ▲ 18.51M | ▼ 13.77M | ▼ 3.57M |
Long Term Debt | 11.37M | ▼ 3.38M | ▲ 24.16M | ▼ 15.75M | ▼ 8.76M | ▼ 2.96M | ▼ 0.00 |
Deferred Revenue Non Current | 3.46M | ▼ 3.15M | ▼ 2.83M | ▼ 0.00 | ▲ 1.15M | ▼ 1.04M | ▼ 0.00 |
Deferred Tax Liabilities Non Current | 585.00K | ▼ 537.00K | ▲ 91.68M | ▼ 0.00 | ▲ 85.29M | ▼ 0.00 | 0.00 |
Other Non Current Liabilities | 82.98M | ▲ 93.29M | ▼ 490.00K | ▲ 88.66M | ▼ 81.00K | ▲ 7.91M | ▼ 1.38M |
Total Non Current Liabilities | 98.40M | ▲ 100.35M | ▲ 119.16M | ▼ 104.41M | ▼ 95.28M | ▼ 11.90M | ▼ 1.38M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | 0.00 | ▲ 4.61M | ▼ 3.72M | ▲ 4.82M | ▼ 4.66M | ▼ 0.00 |
Total Liabilities | 112.06M | ▲ 116.28M | ▲ 132.77M | ▼ 122.05M | ▼ 113.79M | ▼ 25.67M | ▼ 4.95M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 51.00K | ▲ 78.00K | ▲ 79.00K | ▲ 98.00K | ▲ 137.00K | ▼ 8.00K | ▲ 17.00K |
Retained Earnings | -297.87M | ▼ -345.02M | ▼ -398.11M | ▼ -438.49M | ▼ -473.58M | ▲ -425.83M | ▼ -439.71M |
Accumulated Other Comprehensive Income Loss | -8.44M | ▼ -8.94M | ▼ -9.55M | ▲ 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 269.75M | ▲ 358.14M | ▲ 366.16M | ▲ 382.64M | ▲ 437.55M | ▲ 447.64M | ▲ 458.00M |
Total Stockholders Equity | -36.51M | ▲ 4.25M | ▼ -41.42M | ▼ -55.75M | ▲ -35.89M | ▲ 21.81M | ▼ 18.31M |
Total Equity | -36.51M | ▲ 4.25M | ▼ -41.42M | ▼ -55.75M | ▲ -35.89M | ▲ 21.81M | ▼ 18.31M |
Total Liabilities And Stockholders Equity | 75.55M | ▲ 120.53M | ▼ 91.36M | ▼ 66.30M | ▲ 77.89M | ▼ 47.49M | ▼ 23.26M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 75.55M | ▲ 120.53M | ▼ 91.36M | ▼ 66.30M | ▲ 77.89M | ▼ 47.49M | ▼ 23.26M |
Total Investments | 7.57M | ▲ 17.74M | ▲ 51.45M | ▼ 15.61M | ▲ 38.97M | ▼ 495.00K | ▼ 0.00 |
Total Debt | 19.10M | ▼ 11.99M | ▲ 29.76M | ▼ 25.60M | ▼ 18.62M | ▼ 10.42M | ▼ 0.00 |
Net Debt | -33.81M | ▼ -75.98M | ▲ 15.07M | ▼ -1.68M | ▲ 5.96M | ▼ -4.85M | ▼ -13.39M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | |
---|---|---|---|---|---|---|---|
Net Income | -9.89M | ▼ -12.56M | ▼ -14.42M | ▲ -8.92M | ▲ -7.92M | ▲ -7.48M | ▲ -1.36M |
Depreciation And Amortization | 356.00K | ▼ 140.00K | ▲ 515.00K | ▼ 382.00K | ▲ 461.00K | ▼ 342.00K | ▼ 0.00 |
Deferred Income Tax | -628.00K | ▲ -23.00K | ▲ 96.00K | ▼ 0.00 | ▲ 810.00K | ▼ 0.00 | 0.00 |
Stock Based Compensation | 1.05M | ▲ 1.23M | ▲ 1.28M | ▼ 1.08M | ▲ 1.13M | ▼ 652.00K | ▼ 378.00K |
Change In Working Capital | -500.00K | ▲ 578.00K | ▼ -616.00K | ▲ 1.84M | ▼ -1.72M | ▲ 208.00K | ▼ -193.00K |
Accounts Receivables | -190.00K | ▲ 138.00K | ▼ -188.00K | ▲ 493.00K | ▼ -7.00K | ▲ 203.00K | ▼ 43.00K |
Inventory | -140.00K | ▲ 2.00K | ▼ -411.00K | ▲ 223.00K | ▼ -115.00K | ▼ -317.00K | ▲ -179.00K |
Accounts Payables | 89.00K | ▼ 55.00K | ▼ -862.00K | ▲ 842.00K | ▼ -170.00K | ▲ 526.00K | ▼ -283.00K |
Other Working Capital | -259.00K | ▲ 383.00K | ▲ 845.00K | ▼ 285.00K | ▼ -1.43M | ▲ -204.00K | ▲ 226.00K |
Other Non Cash Items | 2.93M | ▼ 1.64M | ▼ -1.01M | ▲ -718.00K | ▼ -766.00K | ▲ 869.00K | ▼ -1.79M |
Net Cash Provided By Operating Activities | -6.68M | ▼ -8.99M | ▼ -14.16M | ▲ -6.33M | ▼ -8.00M | ▲ -5.41M | ▲ -2.96M |
Investments In Property Plant And Equipment | 90.00K | ▼ -246.00K | ▲ -242.00K | ▼ -1.63M | ▲ -28.00K | ▼ -48.00K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.69M | ▲ 0.00 |
Purchases Of Investments | -7.57M | ▼ -17.71M | ▼ -18.14M | ▲ -5.79M | ▼ -16.59M | ▲ -492.00K | ▲ 0.00 |
Sales Maturities Of Investments | 0.00 | ▲ 6.00M | ▲ 25.28M | ▼ 13.20M | ▼ 13.00M | ▼ 3.20M | ▼ 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -821.00K | ▲ 1.69M | ▼ 0.00 |
Net Cash Used For Investing Activities | -7.48M | ▼ -11.96M | ▲ 6.89M | ▼ 5.78M | ▼ -4.44M | ▲ 2.66M | ▼ 0.00 |
Debt Repayment | 0.00 | ▼ -2.01M | ▼ -12.33M | ▲ -2.08M | ▲ -2.08M | ▼ -2.18M | ▲ 0.00 |
Common Stock Issued | 2.57M | ▲ 52.45M | ▼ 0.00 | ▲ 9.94M | ▼ 8.36M | ▼ 7.79M | ▼ 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.46M | ▲ 914.00K | ▲ 12.34M | ▼ 0.00 | ▲ 5.56M | ▼ -315.00K | ▲ 0.00 |
Net Cash Used Provided By Financing Activities | -883.00K | ▲ 51.36M | ▼ 1.00K | ▲ 7.85M | ▲ 11.84M | ▼ 5.30M | ▲ 8.94M |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash | -15.03M | ▲ 30.41M | ▼ -7.27M | ▲ 7.30M | ▼ -608.00K | ▲ 2.54M | ▲ 5.98M |
Cash At End Of Period | 52.90M | ▲ 88.15M | ▼ 14.68M | ▲ 27.27M | ▼ 12.66M | ▲ 20.28M | ▼ 13.39M |
Cash At Beginning Of Period | 67.94M | ▼ 57.74M | ▼ 21.95M | ▼ 19.97M | ▼ 13.27M | ▲ 17.73M | ▼ 7.41M |
Operating Cash Flow | -6.68M | ▼ -8.99M | ▼ -14.16M | ▲ -6.33M | ▼ -8.00M | ▲ -5.41M | ▲ -2.96M |
Capital Expenditure | 90.00K | ▼ -246.00K | ▲ -242.00K | ▼ -1.63M | ▲ -28.00K | ▼ -48.00K | ▲ 0.00 |
Free Cash Flow | -6.59M | ▼ -9.24M | ▼ -14.40M | ▲ -7.96M | ▼ -8.03M | ▲ -5.46M | ▲ -2.96M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)